Biotage AB 

SEK182.2
0
+SEK0+0% Thursday 15:23

統計

當日最高
182.5
當日最低
179.6
52週最高
238.6
52週最低
115.4
成交量
731
平均成交量
17,478
市值
12.52B
市盈率
-
股息收益率
0.83%
股息
1.51

即將到來

股息

0.83%股息收益率
10年增長
10.31%
5年增長率
1.3%
3年增長率
2.17%
1年增長率
N/A

收益

23Oct預期
Q1 2024
Q2 2024
下一個
0.54
0.58
0.62
0.66
預期每股收益
0.663115004224003
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 0GRP.LSE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Show more...
首席執行官
Mr. Andrew Kellett
員工
667
國家
SE
ISIN
SE0000454746

上市公司